Selective deposition of 4-repeat tau in cerebral infarcts

Journal of Neuropathology and Experimental Neurology

Volumn 68, Issue 9, 2009, Pages 1029-1036

  Ichihara, Kazuaki ^a,c   Uchihara, Toshiki ^a   Nakamura, Ayako ^a   Suzuki, Yoshio ^b   Mizutani, Tomohiko ^c  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b ASAHI GENERAL HOSPITAL   (Japan)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

4 repeat; Campbell Switzer; Cerebral infarct; Dark neurons; Gallyas staining; Tau

Indexed keywords

ISOPROTEIN; TAU PROTEIN;

AGED; ARTICLE; BRAIN INFARCTION; CELL INCLUSION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; SILVER STAINING;

AGED; AGED, 80 AND OVER; CEREBRAL INFARCTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MALE; MIDDLE AGED; NEURONS; PROTEIN ISOFORMS; SILVER STAINING; TAU PROTEINS;

EID: 70349577129     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181b56bf4     Document Type: Article

References (54)

1. Murphy DB, Borisy GG. Association of high-molecular-weight proteins with microtubules and their role in microtubule assembly in vitro. Proc Natl Acad Sci U S A 1975;72:2696-700
2. Weingarten MD, Lockwood AH, Hwo SY, et al. A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 1975;72: 1858-62
3. Goedert M, Spillantini MG, Potier MC, et al. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain. Embo J 1989;8:393-99 (Pubitemid 19274956)
4. Goedert M, Wischik CM, Crowther RA, et al. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A 1988;85:4051-55
5. Lee G, Cowan N, Kirschner M. The primary structure and heterogeneity of tau protein from mouse brain. Science 1988;239:285-88 (Pubitemid 18061495)
6. Delacourte A, Robitaille Y, Sergeant N, et al. Specific pathological Tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 1996;55:159-68
7. Dickson DW. Neuropathology of Pick's disease. Neurology 2001;56: S16YS20
8. Rizzini C, Goedert M, Hodges JR, et al. Tau gene mutation K257T causes a tauopathy similar to Pick's disease. J Neuropathol Exp Neurol 2000;59:990-1001
9. Uchihara T. Silver diagnosis in neuropathology: Principles, practice and revised interpretation. Acta Neuropathol 2007;113:483-99 (Pubitemid 46672595)
10. Uchihara T, Tsuchiya K, Kondo H, et al. Widespread appearance of Alz-50 immunoreactive neurons in the human brain with cerebral infarction. Stroke 1995;26:2145-48
11. Uchihara T, Nakamura A, Arai T, et al. Microglial tau undergoes phosphorylation-independent modification after ischemia. Glia 2004;45: 180-87 (Pubitemid 38196994)
12. de Silva R, Lashley T, Gibb G, et al. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 2003;29:288-302 (Pubitemid 36718177)
13. Mercken M, Vandermeeren M, Lübke U, et al. Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 1992;84:265-72
14. Sergeant N, Wattez A, Delacourte A. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively "exon 10" isoforms. J Neurochem 1999; 72:1243-49 (Pubitemid 29085040)
15. Tolnay M, Probst A. Review: Tau protein pathology in Alzheimer's disease and related disorders. Neuropathol Appl Neurobiol 1999;25: 171-87 (Pubitemid 29313222)
16. Togo T, Sahara N, Yen SH, et al. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 2002;61:547-56 (Pubitemid 34603003)
17. Tolnay M, Sergeant N, Ghestem A, et al. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms. Acta Neuropathol 2002;104:425-34 (Pubitemid 36075409)
18. Sakai K, Piao YS, Kikugawa K, et al. Corticobasal degeneration with focal, massive tau accumulation in the subcortical white matter astrocytes. Acta Neuropathol 2006;112:341-48 (Pubitemid 44275889)
19. Schultz C, Ghebremedhin E, Del Tredici K, et al. High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe. Neurobiol Aging 2004;25:397-405 (Pubitemid 38220974)
20. Dewar D, Graham DI, Teasdale GM, et al. Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat. Acta Neuropathol 1993;86:623-29 (Pubitemid 23346281)
21. Kato T, Hirano A, Katagiri T, et al. Neurofibrillary tangle formation in the nucleus basalis of Meynert ipsilateral to a massive cerebral infarct. Ann Neurol 1988;23:620-23
22. Dewar D, Dawson D. Tau protein is altered by focal cerebral ischaemia in the rat: An immunohistochemical and immunoblotting study. Brain Res 1995;684:70-78
23. Geddes JW, Schwab C, Craddock S, et al. Alterations in tau immunostaining in the rat hippocampus following transient cerebral ischemia. J Cereb Blood Flow Metab 1994;14:554-64 (Pubitemid 24198397)
24. Shackelford DA, Yeh RY. Dephosphorylation of tau during transient forebrain ischemia in the rat. Mol Chem Neuropathol 1998;34:103-20 (Pubitemid 29168572)
25. Wen Y, Yang S, Liu R, et al. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's diseaseYlike tauopathy in female rats. J Biol Chem 2004;279:22684-92 (Pubitemid 38679469)
26. Davis DR, Brion JP, Couck AM, et al. The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and beta-amyloid in primary rat cortical neuronal cultures. Biochem J 1995;309:941-49
27. Matsuo ES, Shin RW, Billingsley ML, et al. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994;13: 989-1002 (Pubitemid 24347311)
28. Pollock NJ, Wood JG. Differential sensitivity of the microtubule- associated protein, tau, in Alzheimer's disease tissue to formalin fixation. J Histochem Cytochem 1988;36:1117-21
29. Hanger DP, Gibb GM, de Silva R, et al. The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies. FEBS Lett 2002;531:538-42 (Pubitemid 35336082)
30. Uchihara T, Nakamura A, Yamazaki M, et al. Tau-positive neurons in corticobasal degeneration and Alzheimer's diseaseVDistinction by thiazin red and silver impregnations. Acta Neuropathol 2000;100:385-89 (Pubitemid 30497007)
31. Uchihara T, Shibuya K, Nakamura A, et al. Silver stains distinguish tau-positive structures in corticobasal degeneration/progressive supra-nuclear palsy and in Alzheimer's disease - Comparison between Gallyas and Campbell-Switzer methods. Acta Neuropathol 2005;109:299-305 (Pubitemid 41166599)
32. Bancher C, Brunner C, Lassmann H, et al. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 1989;477:90-99 (Pubitemid 19026942)
33. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994;87:554-67 (Pubitemid 24158408)
34. Uchihara T, Nakamura A, Yamazaki M, et al. Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol 2001;101:535-39 (Pubitemid 32684750)
35. Takahashi T, Amano N, Hanihara T, et al. Corticobasal degeneration: Widespread argentophilic threads and glia in addition to neurofibrillary tangles. Similarities of cytoskeletal abnormalities in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci 1996;138:66-77
36. Uchihara T, Mitani K, Mori H, et al. Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer's disease or progressive supranuclear palsy. Acta Neuropathol 1994; 88:379-83 (Pubitemid 24309403)
37. Czurkó A, Nishino H. "Collapsed" (argyrophilic, dark) neurons in rat model of transient focal cerebral ischemia. Neurosci Lett 1993;162:71-74 (Pubitemid 23347948)
38. Kövesdi E, Pál J, Gallyas F. The fate of "dark" neurons produced by transient focal cerebral ischemia in a non-necrotic and non-excitotoxic environment: Neurobiological aspects. Brain Res 2007;1147:272-83 (Pubitemid 46584662)
39. Gallyas F, Zoltay G. An immediate light microscopic response of neuronal somata, dendrites and axons to non-contusing concussive head injury in the rat. Acta Neuropathol 1992;83:386-93
40. Gallyas F, Zoltay G, Balás I. An immediate light microscopic response of neuronal somata, dendrites and axons to contusing concussive head injury in the rat. Acta Neuropathol 1992;83:394-401
41. Gallyas F, Zoltay G, Dames W. Formation of "dark" (argyrophilic) neurons of various origin proceeds with a common mechanism of biophysical nature (a novel hypothesis). Acta Neuropathol 1992;83: 504-9
42. Gallyas F, Zoltay G, Horváth Z, et al. An immediate morphopathologic response of neurons to electroshock; a reliable model for producing "dark" neurons in experimental neuropathology. Neurobiology (Bp) 1993;1:133-46
43. Gallyas F, Farkas O, Mazlo M. Gel-to-gel phase transition may occur in mammalian cells: Mechanism of formation of "dark" (compacted) neurons. Biol Cell 2004;96:313-24 (Pubitemid 38618759)
44. Gallyas F, Pál J, Bukovics P. Supravital microwave experiments support that the formation of "dark" neurons is propelled by phase transition in an intracellular gel system. Brain Res 2009;1270:152-56
45. Kherani ZS, Auer RN. Pharmacologic analysis of the mechanism of dark neuron production in cerebral cortex. Acta Neuropathol 2008;116: 447-52
46. Sindou P, Couratier P, Barthe D, et al. A dose-dependent increase of Tau immunostaining is produced by glutamate toxicity in primary neuronal cultures. Brain Res 1992;572:242-46
47. Sindou P, Lesort M, Couratier P, et al. Glutamate increases tau phosphorylation in primary neuronal cultures from fetal rat cerebral cortex. Brain Res 1994;646:124-28
48. Jenkins LW, Povlishock JT, Lewelt W, et al. The role of postischemic recirculation in the development of ischemic neuronal injury following complete cerebral ischemia. Acta Neuropathol 1981;55:205-20 (Pubitemid 12240162)
49. Kirino T, Sano K. Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol 1984;62:201-8 (Pubitemid 14178596)
50. Auer RN, Kalimo H, Olsson Y, et al. The temporal evolution of hypoglycemic brain damage. I. Light- and electron-microscopic findings in the rat cerebral cortex. Acta Neuropathol 1985;67:13-24 (Pubitemid 15021207)
51. Johnson JE Jr. The occurrence of dark neurons in the normal and deafferentated lateral vestibular nucleus in the rat: Observations by light and electron microscopy. Acta Neuropathol 1975;31:117-27
52. de Souza Queiroz L, de Paula Eduardo RM. Occurrence of dark neurons in living mechanically injured rat neocortex. Acta Neuropathol 1977;38:45-58
53. Shimizu H, Kakita A, Takahashi H. Spinal cord tau pathology in cervical spondylotic myelopathy. Acta Neuropathol 2008;115:185-92
54. McKee AC, Cantu RC, Nowinski CJ, et al. Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 2009:68:709-35